B-PRECURSOR ALL

Clinical trials for B-PRECURSOR ALL explained in plain language.

Never miss a new study

Get alerted when new B-PRECURSOR ALL trials appear

Sign up with your email to follow new studies for B-PRECURSOR ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 2

New Dual-Target CAR T-Cell therapy aims to beat relapsed childhood cancers

Disease control Recruiting now

This study tests a new type of CAR T-cell therapy that targets two proteins, CD19 and CD22, on cancer cells. It is for children and young adults aged 3 to 39 with B-cell cancers like leukemia or lymphoma that have not been cured by standard treatments. Participants receive their …

Matched conditions: B-PRECURSOR ALL

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

B-PRECURSOR ALL

Get alerted when new B-PRECURSOR ALL trials appear

New Dual-Target CAR T-Cell therapy aims to beat relapsed childhood cancers